Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Mutagenesis of cysteine 81 prevents dimerization of the APS1 subunit of ADP-glucose pyrophosphorylase and alters diurnal starch turnover in Arabidopsis thaliana leaves.

Hädrich N, Hendriks JH, Kötting O, Arrivault S, Feil R, Zeeman SC, Gibon Y, Schulze WX, Stitt M, Lunn JE.

Plant J. 2012 Apr;70(2):231-42. doi: 10.1111/j.1365-313X.2011.04860.x. Epub 2011 Dec 28.

2.

Does experience in colposcopy improve identification of high grade abnormalities?

Bekkers RL, van de Nieuwenhof HP, Neesham DE, Hendriks JH, Tan J, Quinn MA.

Eur J Obstet Gynecol Reprod Biol. 2008 Nov;141(1):75-8. doi: 10.1016/j.ejogrb.2008.07.007. Epub 2008 Aug 30.

PMID:
18760872
3.

Personality factors and breast cancer risk: a 13-year follow-up.

Bleiker EM, Hendriks JH, Otten JD, Verbeek AL, van der Ploeg HM.

J Natl Cancer Inst. 2008 Feb 6;100(3):213-8. doi: 10.1093/jnci/djm280. Epub 2008 Jan 29.

PMID:
18230799
4.

Importance of comparison of current and prior mammograms in breast cancer screening.

Roelofs AA, Karssemeijer N, Wedekind N, Beck C, van Woudenberg S, Snoeren PR, Hendriks JH, Rosselli del Turco M, Bjurstam N, Junkermann H, Beijerinck D, Séradour B, Evertsz CJ.

Radiology. 2007 Jan;242(1):70-7.

PMID:
17185661
5.

Sugar-induced increases in trehalose 6-phosphate are correlated with redox activation of ADPglucose pyrophosphorylase and higher rates of starch synthesis in Arabidopsis thaliana.

Lunn JE, Feil R, Hendriks JH, Gibon Y, Morcuende R, Osuna D, Scheible WR, Carillo P, Hajirezaei MR, Stitt M.

Biochem J. 2006 Jul 1;397(1):139-48.

6.

Effect of soft-copy display supported by CAD on mammography screening performance.

Roelofs AA, van Woudenberg S, Otten JD, Hendriks JH, Bödicker A, Evertsz CJ, Karssemeijer N.

Eur Radiol. 2006 Jan;16(1):45-52. Epub 2005 Aug 25.

PMID:
16132926
7.

US correlation for MRI-detected breast lesions in women with familial risk of breast cancer.

Sim LS, Hendriks JH, Bult P, Fook-Chong SM.

Clin Radiol. 2005 Jul;60(7):801-6.

PMID:
15978891
8.

Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.

Otten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, de Koning HJ, Holland R.

J Natl Cancer Inst. 2005 May 18;97(10):748-54.

PMID:
15900044
9.

Use of prior mammograms in the classification of benign and malignant masses.

Varela C, Karssemeijer N, Hendriks JH, Holland R.

Eur J Radiol. 2005 Nov;56(2):248-55.

PMID:
15890483
10.

A Robot-based platform to measure multiple enzyme activities in Arabidopsis using a set of cycling assays: comparison of changes of enzyme activities and transcript levels during diurnal cycles and in prolonged darkness.

Gibon Y, Blaesing OE, Hannemann J, Carillo P, Höhne M, Hendriks JH, Palacios N, Cross J, Selbig J, Stitt M.

Plant Cell. 2004 Dec;16(12):3304-25. Epub 2004 Nov 17.

11.

Breast ultrasound in women with familial risk of breast cancer.

Sim LS, Hendriks JH, Fook-Chong SM.

Ann Acad Med Singapore. 2004 Sep;33(5):600-6.

12.
13.

Reproducibility of mammographic classifications for non-palpable suspect lesions with microcalcifications.

Pijnappel RM, Peeters PH, Hendriks JH, Mali WP.

Br J Radiol. 2004 Apr;77(916):312-4.

PMID:
15107321
14.

The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers.

Kaas R, Kroger R, Hendriks JH, Besnard AP, Koops W, Pameijer FA, Prevoo W, Loo CE, Muller SH.

Eur Radiol. 2004 Sep;14(9):1647-53. Epub 2004 Apr 9.

PMID:
15083333
15.

Independent double reading of screening mammograms in The Netherlands: effect of arbitration following reader disagreements.

Duijm LE, Groenewoud JH, Hendriks JH, de Koning HJ.

Radiology. 2004 May;231(2):564-70. Epub 2004 Mar 24.

PMID:
15044742
16.

Nationwide breast cancer screening programme fully implemented in The Netherlands.

Fracheboud J, de Koning HJ, Boer R, Groenewoud JH, Verbeek AL, Broeders MJ, van Ineveld BM, Hendriks JH, de Bruyn AE, Holland R, van der Maas PJ; National Evaluation Team for Breast cancer screening in The Netherlands.

Breast. 2001 Feb;10(1):6-11.

17.

Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions.

Pijnappel RM, van den Donk M, Holland R, Mali WP, Peterse JL, Hendriks JH, Peeters PH.

Br J Cancer. 2004 Feb 9;90(3):595-600.

18.

[The treatment of ductal carcinoma in situ (DCIS) of the breast].

Westenberg AH, Rutgers EJ, Peterse JL, Hendriks JH, Beex LV, van Tienhoven G.

Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2157-61. Review. Dutch.

PMID:
14626831
19.

Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions.

Verkooijen HM, Peterse JL, Schipper ME, Buskens E, Hendriks JH, Pijnappel RM, Peeters PH, Borel Rinkes IH, Mali WP, Holland R; COBRA Study Group.

Eur J Cancer. 2003 Oct;39(15):2187-91.

PMID:
14522377
20.
21.

Use of previous screening mammograms to identify features indicating cases that would have a possible gain in prognosis following earlier detection.

Broeders MJ, Onland-Moret NC, Rijken HJ, Hendriks JH, Verbeek AL, Holland R.

Eur J Cancer. 2003 Aug;39(12):1770-5.

PMID:
12888373
22.

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ; National Evaluation Team for Breast Cancer Screening.

Lancet. 2003 Apr 26;361(9367):1411-7. Review.

PMID:
12727393
23.

Computer-aided detection versus independent double reading of masses on mammograms.

Karssemeijer N, Otten JD, Verbeek AL, Groenewoud JH, de Koning HJ, Hendriks JH, Holland R.

Radiology. 2003 Apr;227(1):192-200. Epub 2003 Feb 28.

PMID:
12616008
24.

Repeated mammographic screening reduces breast cancer mortality along the continuum of age.

Broeders MJ, Verbeek AL, Straatman H, Peer PG, Jong PC, Beex LV, Hendriks JH, Holland R.

J Med Screen. 2002;9(4):163-7.

PMID:
12518006
25.
26.

Diagnostic strategies in non-palpable breast lesions.

Pijnappel RM, Peeters PH, van den Donk M, Holland R, Hendriks JH, Deurloo EE, Mali WP.

Eur J Cancer. 2002 Mar;38(4):550-5.

PMID:
11872348
27.

Proton and electron pathways in the bacterial nitric oxide reductase.

Hendriks JH, Jasaitis A, Saraste M, Verkhovsky MI.

Biochemistry. 2002 Feb 19;41(7):2331-40.

PMID:
11841226
28.

Reaction of carbon monoxide with the reduced active site of bacterial nitric oxide reductase.

Hendriks JH, Prior L, Baker AR, Thomson AJ, Saraste M, Watmough NJ.

Biochemistry. 2001 Nov 6;40(44):13361-9.

PMID:
11683646
29.

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JH, Laheij RJ, Massuger L, van Die LE, Wobbes T, Barentsz JO.

J Natl Cancer Inst. 2001 Jul 18;93(14):1095-102.

PMID:
11459871
30.

Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997.

Broeders MJ, Peer PG, Straatman H, Beex LV, Hendriks JH, Holland R, Verbeek AL.

Int J Cancer. 2001 Apr 15;92(2):303-8.

31.
32.

Automated classification of clustered microcalcifications into malignant and benign types.

Veldkamp WJ, Karssemeijer N, Otten JD, Hendriks JH.

Med Phys. 2000 Nov;27(11):2600-8.

PMID:
11128313
33.

An automatic method to discriminate malignant masses from normal tissue in digital mammograms.

te Brake GM, Karssemeijer N, Hendriks JH.

Phys Med Biol. 2000 Oct;45(10):2843-57.

PMID:
11049175
34.

[Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].

van Dijck JA, Hendriks JH, Holland R, Schouten LJ, Verbeek AL.

Ned Tijdschr Geneeskd. 2000 Jun 3;144(23):1119-24. Dutch.

PMID:
10876707
35.

Parity and mammographic breast density in relation to breast cancer risk: indication of interaction.

van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL.

Eur J Cancer Prev. 2000 Apr;9(2):105-11.

PMID:
10830577
36.

High mammographic breast density and its implications for the early detection of breast cancer.

van Gils CH, Otten JD, Hendriks JH, Holland R, Straatman H, Verbeek AL.

J Med Screen. 1999;6(4):200-4.

PMID:
10693066
37.

Changes in mammographic breast density and concomitant changes in breast cancer risk.

van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Otten JD, Straatman H, Verbeek AL.

Eur J Cancer Prev. 1999 Dec;8(6):509-15.

PMID:
10643940
38.

[Reading screening mammograms with the help of neural networks].

Karssemeijer N, Veldkamp WJ, te Brake GM, Hendriks JH.

Ned Tijdschr Geneeskd. 1999 Nov 6;143(45):2232-6. Review. Dutch.

PMID:
10578420
39.

Interval cancers in the Dutch breast cancer screening programme.

Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ.

Br J Cancer. 1999 Nov;81(5):912-7.

40.

Value of breast imaging in women with painful breasts: observational follow up study.

Duijm LE, Guit GL, Hendriks JH, Zaat JO, Mali WP.

BMJ. 1998 Nov 28;317(7171):1492-5.

41.

Mammographic breast density and risk of breast cancer: masking bias or causality?

van Gils CH, Otten JD, Verbeek AL, Hendriks JH.

Eur J Epidemiol. 1998 Jun;14(4):315-20.

PMID:
9690746
42.

Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.

van Gils CH, Otten JD, Verbeek AL, Hendriks JH, Holland R.

J Epidemiol Community Health. 1998 Apr;52(4):267-71.

43.

Automated detection of breast carcinomas not detected in a screening program.

te Brake GM, Karssemeijer N, Hendriks JH.

Radiology. 1998 May;207(2):465-71.

PMID:
9577496
44.

Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.

Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Hendriks JH, Verbeek AL, van Ineveld BM, de Bruyn AE, van der Maas PJ.

Int J Cancer. 1998 Mar 2;75(5):694-8.

45.

Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.

Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, Straatman H, Werre JM.

Int J Cancer. 1997 Jan 17;70(2):164-8.

46.

Mammographic changes in postmenopausal women on hormonal replacement therapy.

Marugg RC, van der Mooren MJ, Hendriks JH, Rolland R, Ruijs SH.

Eur Radiol. 1997;7(5):749-55.

PMID:
9166577
47.

Computer-assisted reading of mammograms.

Karssemeijer N, Hendriks JH.

Eur Radiol. 1997;7(5):743-8. Review.

PMID:
9166576
48.

Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment?

Maes RM, Dronkers DJ, Hendriks JH, Thijssen MA, Nab HW.

Br J Radiol. 1997 Jan;70:34-38.

PMID:
9059292
49.

Personality factors and breast cancer development: a prospective longitudinal study.

Bleiker EM, van der Ploeg HM, Hendriks JH, Adèr HJ.

J Natl Cancer Inst. 1996 Oct 16;88(20):1478-82.

PMID:
8841023
50.

Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.

Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, Straatman H, Werre JM.

Int J Cancer. 1996 Jun 11;66(6):727-31.

Supplemental Content

Loading ...
Support Center